Jan 16, 2018 -
TiGenix - American Depositary Shares (NASDAQ: TIG) is up over 80 percent since the start of the year, sending the stock above BTIG's price target.
Jan 12, 2018 - TIG call was good timing, nothing more, but now investors may be looking for additional options.There are 3 other stem cell companies which may provide strong cases for investment.Phase III trials are
Jan 12, 2018 - Takeda launches a friendly offer on TiGenix.The offer significantly undervalues the potential of its main drug candidate.Rejecting the offer and waiting for a better one seems to be the best option.
Jan 09, 2018 - Ablynx has received a $3.1 billion hostile takeover offer from Novo Nordisk.Celgene announced the acquisition of privately held Impact Biomedicines.Axovant announced another failed trial, pushing shar
Jan 08, 2018 - Canaccord Genuity issues rating change for TIG
Jan 08, 2018 - Takeda Pharmaceutical announced Friday morning that it intends to acquire TiGenix NV (TIG) in a deal valued at approximately 520 million euros.
Jan 06, 2018 - Lipocine dropped 10% ahead of Ad Com for its lead product candidate.Ohr’s MAKO study failed to meet primary endpoint.Zafgen provided an update on clinical progress.
Jan 05, 2018 -
Jan 05, 2018 - TiGenix Skyrockets on Acquisition News, Stocks: TIG,XLNX,EA,EBAY,BA,HES,JCI,WYN,ULTA,ILMN,CHK, release date:Jan 05, 2018
Dec 21, 2017 - Synergy’s appointment of new CEO has given the stock a boost. AbbVie announced data for upadacitinib. TiGenix narrows focus.